UPCOMING SESSIONS in ET
Fri, Nov 20, 2026
6:00 – 7:00 AM Bangkok
Sadness, Anger and Fear: Coping With the Emotions of Illness Hamide Eygoren Register
UPCOMING SESSIONS in ET
Fri, Nov 20, 2026 · 6:00 – 7:00 AM Bangkok
Sadness, Anger and Fear: Coping With the Emotions of Illness
Hamide Eygoren
Register
View all sessions

New analyses back Amvuttra as first-line treatment for complex heart cases

Source
Amyloidosis News Today

Injectable therapy shows consistent benefits across high-risk ATTR-CM groups

New analyses back the use of the approved therapy Amvuttra (vutrisiran) as an initial treatment for people with transthyretin amyloidosis with cardiomyopathy (ATTR-CM) who have risk factors such as abnormal heart rhythms or low blood pressure.

The injectable therapy was found to lower the risk of death or recurrent cardiovascular events — acute, sudden incidents causing injury to the heart or brain, primarily due to interrupted blood flow — among ATTR-CM patients with these issues.